Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.01
UHS's Cash to Debt is ranked lower than
56% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. UHS: 0.01 )
UHS' s 10-Year Cash to Debt Range
Min: 0   Max: 0.04
Current: 0.01

0
0.04
Equity to Asset 0.39
UHS's Equity to Asset is ranked higher than
65% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. UHS: 0.39 )
UHS' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.5
Current: 0.39

0.26
0.5
Interest Coverage 6.69
UHS's Interest Coverage is ranked higher than
71% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 6.09 vs. UHS: 6.69 )
UHS' s 10-Year Interest Coverage Range
Min: 4.47   Max: 25.45
Current: 6.69

4.47
25.45
F-Score: 6
Z-Score: 2.64
M-Score: -2.58
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.94
UHS's Operating margin (%) is ranked higher than
85% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 9.44 vs. UHS: 13.94 )
UHS' s 10-Year Operating margin (%) Range
Min: 6.8   Max: 23
Current: 13.94

6.8
23
Net-margin (%) 7.01
UHS's Net-margin (%) is ranked higher than
81% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 5.38 vs. UHS: 7.01 )
UHS' s 10-Year Net-margin (%) Range
Min: 3.51   Max: 7.01
Current: 7.01

3.51
7.01
ROE (%) 15.71
UHS's ROE (%) is ranked higher than
88% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 9.51 vs. UHS: 15.71 )
UHS' s 10-Year ROE (%) Range
Min: 11.01   Max: 19.99
Current: 15.71

11.01
19.99
ROA (%) 6.14
UHS's ROA (%) is ranked higher than
83% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. UHS: 6.14 )
UHS' s 10-Year ROA (%) Range
Min: 3.06   Max: 8.42
Current: 6.14

3.06
8.42
ROC (Joel Greenblatt) (%) 26.06
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 17.97 vs. UHS: 26.06 )
UHS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.55   Max: 54.67
Current: 26.06

13.55
54.67
Revenue Growth (%) 8.90
UHS's Revenue Growth (%) is ranked higher than
78% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. UHS: 8.90 )
UHS' s 10-Year Revenue Growth (%) Range
Min: 8.9   Max: 19.4
Current: 8.9

8.9
19.4
EBITDA Growth (%) 22.40
UHS's EBITDA Growth (%) is ranked higher than
91% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. UHS: 22.40 )
UHS' s 10-Year EBITDA Growth (%) Range
Min: -3.3   Max: 26.7
Current: 22.4

-3.3
26.7
EPS Growth (%) 29.80
UHS's EPS Growth (%) is ranked higher than
93% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 9.30 vs. UHS: 29.80 )
UHS' s 10-Year EPS Growth (%) Range
Min: -9.8   Max: 29.8
Current: 29.8

-9.8
29.8
» UHS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

UHS Guru Trades in Q1 2013

Ron Baron 200,790 sh (New)
Andreas Halvorsen 2,625,972 sh (+24.64%)
Joel Greenblatt 54,597 sh (+13.25%)
Westport Asset Management 1,165,268 sh (-0.76%)
Vanguard Health Care Fund 3,873,600 sh (-3.66%)
Chris Davis 251,300 sh (-7.37%)
Private Capital 699,605 sh (-12.7%)
Jean-Marie Eveillard 630,691 sh (-31.67%)
Steven Cohen 223,995 sh (-37.1%)
Manning & Napier Advisors, Inc 1,197,493 sh (-53.79%)
» More
Q2 2013

UHS Guru Trades in Q2 2013

Mariko Gordon 41,100 sh (New)
Paul Tudor Jones 3,200 sh (New)
Steven Cohen 544,754 sh (+143.2%)
Ron Baron 301,490 sh (+50.15%)
Andreas Halvorsen 3,780,506 sh (+43.97%)
Joel Greenblatt 66,076 sh (+21.02%)
Vanguard Health Care Fund 3,873,600 sh (unchged)
Jean-Marie Eveillard Sold Out
Private Capital 680,545 sh (-2.72%)
Westport Asset Management 1,071,946 sh (-8.01%)
Chris Davis 198,740 sh (-20.92%)
Manning & Napier Advisors, Inc 509,102 sh (-57.49%)
» More
Q3 2013

UHS Guru Trades in Q3 2013

Jim Simons 37,900 sh (New)
Jeremy Grantham 8,229 sh (New)
Ray Dalio 9,800 sh (New)
Joel Greenblatt 123,498 sh (+86.9%)
Ron Baron 405,540 sh (+34.51%)
Mariko Gordon 45,939 sh (+11.77%)
Andreas Halvorsen 4,046,906 sh (+7.05%)
Vanguard Health Care Fund 3,873,600 sh (unchged)
Paul Tudor Jones Sold Out
Westport Asset Management 1,048,332 sh (-2.2%)
Steven Cohen 512,731 sh (-5.88%)
Private Capital 619,012 sh (-9.04%)
Chris Davis 167,300 sh (-15.82%)
Manning & Napier Advisors, Inc 241,470 sh (-52.57%)
» More
Q4 2013

UHS Guru Trades in Q4 2013

Paul Tudor Jones 7,354 sh (New)
Ray Dalio 12,500 sh (+27.55%)
Joel Greenblatt 147,392 sh (+19.35%)
Vanguard Health Care Fund 3,873,600 sh (unchged)
Ron Baron 405,540 sh (unchged)
Jim Simons Sold Out
Mariko Gordon 45,667 sh (-0.59%)
Jeremy Grantham 7,889 sh (-4.13%)
Westport Asset Management 947,332 sh (-9.63%)
Chris Davis 147,600 sh (-11.78%)
Manning & Napier Advisors, Inc 203,258 sh (-15.82%)
Andreas Halvorsen 3,009,890 sh (-25.62%)
Private Capital 401,921 sh (-35.07%)
Steven Cohen 153,273 sh (-70.11%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2013-12-31 Add 27.55%$75.88 - $83.12 $ 74.65-7%12500
Joel Greenblatt 2013-09-30 Add 86.9%0.14%$63.83 - $74.29 $ 74.657%123498
Ron Baron 2013-09-30 Add 34.51%0.04%$63.83 - $74.29 $ 74.657%405540
Ray Dalio 2013-09-30 New Buy0.01%$63.83 - $74.29 $ 74.657%9800
Mariko Gordon 2013-06-30 New Buy0.13%$60.12 - $71.2 $ 74.6513%41100
Jean-Marie Eveillard 2013-06-30 Sold Out 0.13%$60.12 - $71.2 $ 74.6513%0
Ron Baron 2013-06-30 Add 50.15%0.04%$60.12 - $71.2 $ 74.6513%301490
Joel Greenblatt 2013-06-30 Add 21.02%0.03%$60.12 - $71.2 $ 74.6513%66076
Ron Baron 2013-03-31 New Buy0.07%$48.35 - $64.38 $ 74.6531%200790
Jean-Marie Eveillard 2013-03-31 Reduce -31.67%0.05%$48.35 - $64.38 $ 74.6531%630691
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Universal Health Services, Inc.

Baron Funds Comments on Universal Health Services Inc. - Nov 06, 2013

The Fund continues to search for companies that will be long-term beneficiaries of the major changes impacting the U.S. healthcare system. During the past three quarters, we established a position in Universal Health Services, Inc. (UHS), a private hospital company with a unique business model. UHS is a leading operator of acute care hospitals, and it is also the nation's largest operator of behavioral health hospitals, which treat patients with mental illnesses. We believe UHS has an attractive business mix, with approximately half its revenues coming from acute care (i.e., traditional hospitals) and half coming from high-margin, low capital intensive behavioral health hospitals. We believe that both segments should benefit from expanded insurance coverage under healthcare reform.

UHS is the largest provider of behavioral health services in the U.S., with market share of approximately 35% – 40% of freestanding behavioral hospitals. We believe this is an attractive sector within the private hospital industry, which is currently undervalued by the market. This sector has benefitted from lack of additional capacity, the relative absence of consolidated competitors, a favor able reimbursement regime, and modest bad debt expense. We believe that demand for behavioral health services is economically insensitive, as evidenced by UHS's achieving same store revenue growth of approximately 5% in this segment throughout the recession. And, we believe that healthcare reform should lead to an expanded pool of potential paying patients. Broader healthcare coverage is also likely to uncover more previously underdiagnosed and undertreated mentally ill patients. Furthermore, current capacity at UHS's behavioral health facilities is running about 1,000 basis points below its peak, and the margin on incremental patients is high.

In the acute care segment, we believe that UHS should also benefit from lower bad debt expense and higher utilization from expanded insurance coverage. UHS' geographically dispersed acute hospitals benefit from being market share leaders in some of the country's fastest growing markets where population growth is expected to be approximately 9%, twice the national level. In fact, 97% of the company's EBITDA comes from hospitals that are #1 or #2 in their markets; these dominant franchises make UHS a "must have" provider for managed care contracts and positions the company well for narrow networks under healthcare exchanges. Lastly, UHS has the lowest leverage among its for profit peers, leaving flexibility for acquisitions and accretive share repurchases.

From Ron Baron's Baron Funds third quarter 2013 report.


Check out Ron Baron latest stock trades

Westport Asset Management Comments on Universal Health Services Inc. - Aug 08, 2013

By far the biggest contributor to first half performance was the Westport Select Cap Fund's largest holding, Universal Health Services, Inc. (UHS), Class B shares. This operator of acute care and mental health hospitals gained over 38% and contributed 393 basis points to performance. Once again investors focused on the company as a prime beneficiary of the 2014 implementation of the Affordable Care Act, known by most commentators as "Obamacare."

From Westport Asset Management's second quarter 2013 letter.
Check out Westport Asset Management latest stock trades

Top Ranked Articles about Universal Health Services, Inc.

Baron Funds Comments on Universal Health Services Inc.
The Fund continues to search for companies that will be long-term beneficiaries of the major changes impacting the U.S. healthcare system. During the past three quarters, we established a position in Universal Health Services, Inc. (UHS), a private hospital company with a unique business model. UHS is a leading operator of acute care hospitals, and it is also the nation's largest operator of behavioral health hospitals, which treat patients with mental illnesses. We believe UHS has an attractive business mix, with approximately half its revenues coming from acute care (i.e., traditional hospitals) and half coming from high-margin, low capital intensive behavioral health hospitals. We believe that both segments should benefit from expanded insurance coverage under healthcare reform. Read more...
Westport Asset Management Comments on Universal Health Services Inc.
By far the biggest contributor to first half performance was the Westport Select Cap Fund's largest holding, Universal Health Services, Inc. (UHS), Class B shares. This operator of acute care and mental health hospitals gained over 38% and contributed 393 basis points to performance. Once again investors focused on the company as a prime beneficiary of the 2014 implementation of the Affordable Care Act, known by most commentators as "Obamacare." Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 14.90
UHS's P/E(ttm) is ranked higher than
87% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 21.80 vs. UHS: 14.90 )
UHS' s 10-Year P/E(ttm) Range
Min: 8.06   Max: 25.79
Current: 14.9

8.06
25.79
P/B 2.30
UHS's P/B is ranked higher than
61% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 2.29 vs. UHS: 2.30 )
UHS' s 10-Year P/B Range
Min: 1.01   Max: 3.04
Current: 2.3

1.01
3.04
P/S 1.00
UHS's P/S is ranked higher than
66% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. UHS: 1.00 )
UHS' s 10-Year P/S Range
Min: 0.33   Max: 1.17
Current: 1

0.33
1.17
PFCF 16.10
UHS's PFCF is ranked higher than
56% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 15.52 vs. UHS: 16.10 )
UHS' s 10-Year PFCF Range
Min: 8.63   Max: 296.78
Current: 16.1

8.63
296.78
EV-to-EBIT 10.60
UHS's EV-to-EBIT is ranked higher than
85% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 17.82 vs. UHS: 10.60 )
UHS' s 10-Year EV-to-EBIT Range
Min: 4.3   Max: 16.6
Current: 10.6

4.3
16.6
PEG 0.70
UHS's PEG is ranked higher than
92% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 2.00 vs. UHS: 0.70 )
UHS' s 10-Year PEG Range
Min: 0.38   Max: 4.53
Current: 0.7

0.38
4.53
Shiller P/E 20.90
UHS's Shiller P/E is ranked higher than
76% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 24.97 vs. UHS: 20.90 )
UHS' s 10-Year Shiller P/E Range
Min: 8.36   Max: 28.36
Current: 20.9

8.36
28.36

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.30
UHS's Dividend Yield is ranked lower than
92% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. UHS: 0.30 )
UHS' s 10-Year Dividend Yield Range
Min: 0.14   Max: 0.99
Current: 0.3

0.14
0.99
Dividend Payout 0.04
UHS's Dividend Payout is ranked higher than
98% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. UHS: 0.04 )
UHS' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.12
Current: 0.04

0.03
0.12
Yield on cost (5-Year) 0.41
UHS's Yield on cost (5-Year) is ranked lower than
90% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 2.09 vs. UHS: 0.41 )
UHS' s 10-Year Yield on cost (5-Year) Range
Min: 0.19   Max: 1.36
Current: 0.41

0.19
1.36
Share Buyback Rate -0.50
UHS's Share Buyback Rate is ranked higher than
81% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: -1.40 vs. UHS: -0.50 )
UHS' s 10-Year Share Buyback Rate Range
Min: 6.8   Max: -5.7
Current: -0.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 36.60
UHS's Price/Tangible Book is ranked lower than
93% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. UHS: 36.60 )
UHS' s 10-Year Price/Tangible Book Range
Min: 1.59   Max: 39.83
Current: 36.6

1.59
39.83
Price/DCF (Projected) 1.10
UHS's Price/DCF (Projected) is ranked higher than
58% of the 122 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. UHS: 1.10 )
UHS' s 10-Year Price/DCF (Projected) Range
Min: 0.78   Max: 4.14
Current: 1.1

0.78
4.14
Price/Median PS Value 1.40
UHS's Price/Median PS Value is ranked lower than
61% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. UHS: 1.40 )
UHS' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 2.15
Current: 1.4

0.5
2.15
Price/Peter Lynch Fair Value 0.70
UHS's Price/Peter Lynch Fair Value is ranked higher than
90% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. UHS: 0.70 )
UHS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.48   Max: 2.73
Current: 0.7

0.48
2.73
Price/Graham Number 4.60
UHS's Price/Graham Number is ranked lower than
81% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 2.20 vs. UHS: 4.60 )
UHS' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 5.05
Current: 4.6

0.92
5.05
Earnings Yield (Greenblatt) 9.40
UHS's Earnings Yield (Greenblatt) is ranked higher than
86% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 5.50 vs. UHS: 9.40 )
UHS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6   Max: 23.1
Current: 9.4

6
23.1
Forward Rate of Return (Yacktman) 22.64
UHS's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. UHS: 22.64 )
UHS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9.7   Max: 27.1
Current: 22.64

9.7
27.1

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:UHID.USA, UHS.Germany
Universal Health Services, Inc., is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. The Company owned and/or operated 23 acute care hospitals and 197 behavioral health centers located in 37 states, Washington, D.C., Puerto Rico and the U.S. Virgin Islands. Services provided by hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. The Company provides capital resources as well as management services to facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. The Company's reportable operating segments consist of acute care hospital services and behavioral health care services. The 'Other' segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and its behavioral health centers are certified as providers of Medicare and Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care. Most state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. The Company's hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. The Company faces competition for acquisition candidates mainly from other for-profit health care companies, as well as from not-for-profit

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide